Biogen, AbbVie once-monthly MS injection wins U.S. FDA approval
May 27, 2016 at 18:19 PM EDT
May 27 (Reuters) - The U.S. Food and Drug Administration on Friday approved a once-monthly injection for multiple sclerosis from Biogen Inc and AbbVie Inc.
